Paper
0
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Authors
Jordi Bruix,Shukui Qin
Philippe Merle,Alessandro Granito,Yi‐Hsiang Huang,G. Bodoky,Marc Pracht,Osamu Yokosuka,Olivier Rosmorduc,В. Бредер,René Gérolami,Gianluca Masi,Paul Ross,Tianqiang Song,Jean-Pierre Bronowicki,Isabelle Ollivier‐Hourmand,Masatoshi Kudo,Ann‐Lii Cheng,Josep Llovet,Richard Finn,Marie-Aude LeBerre,Annette Baumhauer,Gerold Meinhardt,Guohong Han,René Gerolami
+23 authors
,Jean‐Pierre BronowickiJournal
Published
Dec 5, 2016
Show more
Save
Tip0
TipSave